Dr. Torsten Hoffmann is a seasoned Senior Drug Discovery Consultant with extensive experience in medicinal chemistry, pharmacology, and toxicology. They served as Senior Vice President of Drug Discovery at Taros Chemicals and held a significant leadership role as Chief Scientific Officer at Zealand Pharma, where they advanced a robust R&D pipeline. Dr. Hoffmann has contributed to various advisory boards and consultancy roles, including at ZeCardio Therapeutics and Silence Therapeutics, supporting innovative drug discovery methodologies. Their academic foundation includes training at The Scripps Research Institute.
This person is not in the org chart
This person is not in any teams
This person is not in any offices